Session » Health Services Research Poster II – ACR/ARHP
-
Abstract Number: 1176
Experiences of Urban First Nations and Métis Patients Accessing and Navigating the Health System for Inflammatory Arthritis Care
-
Abstract Number: 1177
How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the U.S.?
-
Abstract Number: 1178
Patients’ and Healthcare Professionals’ Resource Preferences for a Knowledge Translation Toolkit for Hip and Knee Replacement Rehabilitation
-
Abstract Number: 1179
Achieving Important Improvement in WOMAC Pain and Function By Three Months Post-Surgery Influences Satisfaction 1 Year Following Total Knee Replacement (TKR)
-
Abstract Number: 1180
The Economic Burden of Systemic Lupus Erythematosus (SLE) within a Commercially-Insured Population in the United States Stratified By Disease Severity
-
Abstract Number: 1181
Hydroxychloroquine: Do We All See Eye to Eye? a Single-Site Analysis of Hydroxychloroquine Dosing Compared to 2016 American Academy of Ophthalmology Guidelines
-
Abstract Number: 1182
The Disproportionate High Risk of Re-Fracture after Osteoporotic Treatment in Patients with Autoimmune Diseases
-
Abstract Number: 1183
The Distribution of Insurance in a Population-Based Cohort of SLE: Georgians Organized Against Lupus Cohort, 2012-2016
-
Abstract Number: 1185
Cause and Rate of Hospitalization of Lupus Patients
-
Abstract Number: 1186
Comparison of Biologic Discontinuation in Patients with Elderly-Onset Vs Younger-Onset Rheumatoid Arthritis
-
Abstract Number: 1187
Impact of a Nurse-Led Program of Patient Self-Assessment and Self-Management Axial Spondyloarthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial
-
Abstract Number: 1188
Are Residents Choosing Wisely? Analysis of Adherence to Recommendations of Ordering Anti-Nuclear Antibody Testing in an Internal Medicine Residency Primary Care Clinic
-
Abstract Number: 1189
Secukinumab Versus Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis from Korean Perspective
-
Abstract Number: 1190
Use of Biologic Drugs and Adverse Events in Patients with Rheumatic Disease: DATA from the Mexican Biologics Registry